Testmate Health Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$6M
- Investors
-
18
Testmate Health General Information
Description
Developer of a disposable test kit designed to detect and diagnose sexually transmitted infections. The company's kit leverages deoxyribonucleic acid isothermal technology to detect any infectious disease with an identifiable DNA strand, enabling individuals, public health programs, and healthcare providers focused on sexual health and women's health to access timely testing, reduce dependence on clinic visits, and improve early identification and treatment pathways.
Contact Information
Website
www.testmatehealth.comCorporate Office
- StartLab Building Alanine
- Route de la Corniche 5
- 1066 Lausanne
- Switzerland
Corporate Office
- StartLab Building Alanine
- Route de la Corniche 5
- 1066 Lausanne
- Switzerland
Testmate Health Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Seed Round | 02-May-2024 | $6M | Completed | Generating Revenue | ||
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Accelerator/Incubator | 02-Mar-2022 | Completed | Generating Revenue | |||
| 4. Seed Round | 21-Oct-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 10-Jun-2020 | $93.2K | $93.2K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 15-May-2019 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Testmate Health Patents
Testmate Health Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026027686-A1 | Nucleic acid amplification device | Pending | 31-Jul-2024 | ||
| EP-4828109-A2 | Devices and methods for biological sample processing | Pending | 20-Dec-2023 | ||
| WO-2025133361-A3 | Devices and methods for biological sample processing | Inactive | 20-Dec-2023 | ||
| US-20260357331-A1 | Devices and methods for nucleic acid amplification from biological samples | Pending | 20-Dec-2023 | ||
| WO-2025133361-A2 | Devices and methods for nucleic acid amplification from biological samples | Inactive | 20-Dec-2023 | B01L3/502 |
Testmate Health Signals
Testmate Health Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| DART Ventures | Venture Capital | Minority | ||
| Foreground Capital | Venture Capital | Minority | ||
| Gaingels | Venture Capital | Minority | ||
| Lichtsteiner Foundation | Limited Partner | Minority | ||
| Zürcher Kantonalbank | Asset Manager | Minority |
Testmate Health FAQs
-
When was Testmate Health founded?
Testmate Health was founded in 2018.
-
Where is Testmate Health headquartered?
Testmate Health is headquartered in Lausanne, Switzerland.
-
What is the size of Testmate Health?
Testmate Health has 9 total employees.
-
What industry is Testmate Health in?
Testmate Health’s primary industry is Other Healthcare Technology Systems.
-
Is Testmate Health a private or public company?
Testmate Health is a Private company.
-
What is Testmate Health’s current revenue?
The current revenue for Testmate Health is .
-
How much funding has Testmate Health raised over time?
Testmate Health has raised $7.82M.
-
Who are Testmate Health’s investors?
DART Ventures, Foreground Capital, Gaingels, Lichtsteiner Foundation, and Zürcher Kantonalbank are 5 of 18 investors who have invested in Testmate Health.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process